Literature DB >> 29254091

Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.

Alessandra Dodich1, Chiara Cerami1, Stefano F Cappa2,3, Alessandra Marcone1, Valeria Golzi1, Michele Zamboni1, Maria Cristina Giusti1, Sandro Iannaccone1.   

Abstract

BACKGROUND: Current diagnostic criteria for behavioral variant of frontotemporal dementia (bvFTD) and typical Alzheimer's disease (AD) include a differential pattern of neuropsychological impairments (episodic memory deficit in typical AD and dysexecutive syndrome in bvFTD). There is, however, large evidence of a frequent overlap in neuropsychological features, making the differential diagnosis extremely difficult.
OBJECTIVES: In this retrospective study, we evaluated the diagnostic value of different cognitive and neurobehavioral markers in bvFTD and AD patient groups.
METHODS: We included 95 dementia patients with a clinical and biomarker evidence of bvFTD (n = 48) or typical AD (n = 47) pathology. A clinical 2-year follow-up confirmed clinical classification. Performances at basic cognitive tasks (memory, executive functions, visuo-spatial, language) as well as social cognition skills and neurobehavioral profiles have been recorded. A stepwise logistic regression model compared the neuropsychological profiles between groups and assessed the accuracy of cognitive and neurobehavioral markers in discriminating bvFTD from AD.
RESULTS: Statistical comparison between patient groups proved social cognition and episodic memory impairments as main cognitive signatures of bvFTD and AD neuropsychological profiles, respectively. Only half of bvFTD patients showed attentive/executive deficits, questioning their role as cognitive marker of bvFTD. Notably, the large majority of bvFTD sample (i.e., 70%) poorly performed at delayed recall tasks. Logistic regression analysis identified social cognition performances, Frontal Behavioral Inventory and Mini-Mental State Examination scores as the best combination in distinguishing bvFTD from AD.
CONCLUSION: Social cognition tasks and socio-behavioral questionnaires are recommended in clinical settings to improve the accuracy of early diagnosis of bvFTD.

Entities:  

Keywords:  Alzheimer’s disease; frontotemporal dementia; neurodegenerative disease; neuropsychology; social skills

Mesh:

Substances:

Year:  2018        PMID: 29254091     DOI: 10.3233/JAD-170650

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

Review 1.  Evaluation of Discriminative Detection Abilities of Social Cognition Measures for the Diagnosis of the Behavioral Variant of Frontotemporal Dementia: a Systematic Review.

Authors:  Alessandra Dodich; Chiara Crespi; Gaia C Santi; Stefano F Cappa; Chiara Cerami
Journal:  Neuropsychol Rev       Date:  2020-10-10       Impact factor: 7.444

2.  Exploring the Relationship Between Deficits in Social Cognition and Neurodegenerative Dementia: A Systematic Review.

Authors:  Esther Setién-Suero; Nancy Murillo-García; Manuel Sevilla-Ramos; Georgelina Abreu-Fernández; Ana Pozueta; Rosa Ayesa-Arriola
Journal:  Front Aging Neurosci       Date:  2022-04-27       Impact factor: 5.702

Review 3.  The role of basket trials in drug development for neurodegenerative disorders.

Authors:  Jeffrey Cummings; Arturo Montes; Sana Kamboj; Jorge Fonseca Cacho
Journal:  Alzheimers Res Ther       Date:  2022-05-25       Impact factor: 8.823

4.  Quantitative and qualitative features of executive dysfunction in frontotemporal and Alzheimer's dementia.

Authors:  Andrew M Kiselica; Jared F Benge
Journal:  Appl Neuropsychol Adult       Date:  2019-08-19       Impact factor: 2.248

5.  A Spanish Neuropsychological Battery Discriminates Between the Behavioral Variant of Frontotemporal Dementia and Primary Progressive Aphasia in a Colombian Sample.

Authors:  Lina Velilla; Jonathan Hernández; Margarita Giraldo-Chica; Edmarie Guzmán-Vélez; Yakeel Quiroz; Francisco Lopera
Journal:  Front Neurol       Date:  2021-07-05       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.